Jitendra Badhai
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
PRC2 loss impairs small cell lung cancer tumorigenesis and enhances sensitivity to G9a/GLP inhibition.
Journal: Communications biology
Published: March 02, 2025
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma.
Journal: British journal of cancer
Published: October 13, 2023
Combined Inhibition of EZH2 and FGFR is Synergistic in BAP1-deficient Malignant Mesothelioma.
Journal: Cancer research communications
Published: June 22, 2023
Genetic screens reveal new targetable vulnerabilities in BAP1-deficient mesothelioma.
Journal: Cell reports. Medicine
Published: June 29, 2022
Combined deletion of Bap1, Nf2, and Cdkn2ab causes rapid onset of malignant mesothelioma in mice.
Journal: The Journal of experimental medicine
Published: July 09, 2019
Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 24, 2017
Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells.
Journal: EMBO molecular medicine
Published: January 10, 2014
Chromatin landscapes of retroviral and transposon integration profiles.
Journal: PLoS genetics
Published: October 14, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026